Winship Cancer Institute of Emory University has named Mylin A. Torres, MD the new director of the Glenn Family Breast Center effective January 19th. She succeeds Ruth O’Regan, MD who now heads the University of Wisconsin Division of Hematology and Oncology.

Torres, an associate professor in Emory’s Department of Radiation Oncology and a member of Winship’s Cancer Prevention and Control Program, is a board certified clinician and researcher who focuses on patients with breast cancer. Her research involves clinical trial development, outcomes measures, identifying patients at risk for side effects of breast cancer treatment, and quality of life metrics of breast cancer survivors.

“We are thrilled that Mylin will assume this key Winship leadership role,” says Walter J. Curran, Jr., MD, executive director of Winship. “Her expertise in defining new breast cancer research paradigms and her extraordinary leadership and organizational skills will elevate the stature and operations of the Glenn Family Breast Center.”

The Glenn Family Breast Center is dedicated to improving the treatment of patients with breast cancer through the careful alignment of research with patient-centered care. The center offers patients the opportunity to participate in Winship’s clinical trials and tissue banking and also facilitates basic and translational research relevant to breast cancer.

Torres has received highly competitive research grants from the National Cancer Institute, Radiation Therapy Oncology Group (now NRG Oncology) and Susan G. Komen. She was the recipient of the 2014 Health Care Heroes Rising Star Award from the Atlanta Business Chronicle.

Torres, a native of Savannah, Georgia, graduated magna cum laude from Harvard University. She received her medical degree from Stanford University and completed her residency in radiation oncology at The University of Texas MD Anderson Cancer Center. She also participated in a research fellowship at Hokkaido University in Japan.